Isolation and characterization of raw heparin from dromedary intestine: Evaluation of a new source of pharmaceutical heparin

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 136, Issue 4, 2003, Pages 357-365

  Warda, Mohamad ^a   Gouda, Eman M ^a   Toida, Toshihiko ^b   Chi, Lianli ^c   Linhardt, Robert J ^c  

^a Cairo University   (Egypt)

^b CHIBA UNIVERSITY   (Japan)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Anticoagulant; Disaccharide analysis; Glycosaminoglycan; Heparan sulfate; Heparin; Intestine; One humped camel

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARIN;

ANALYTIC METHOD; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CAMEL; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; INTESTINE; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE;

BOVINAE; CAMELIDAE; CAMELUS DROMEDARIUS; SUIDAE;

EID: 0842346106     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2003.10.009     Document Type: Article

References (28)

1. Bazin H.G., Marques M.A., Owens A.P., Linhardt R.J., Crutcher K.A. Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. Biochemistry. 41:2002;8203-8211.
2. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 4:1962;330-334.
3. Chandrasena L.G., Emmanuel B., Hamar D.W., Howard B.R. A comparative study of ketone body metabolism between the camel (Camelus dromedarius) and the sheep (Ovis aries). Comp. Biochem. Physiol. 64:1979;109-112.
4. Choay J., Petitou M., Lormeau J.C., Sinay P., Casu B., Gatti G. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Commun. 116:1983;492-499.
5. Edens R.E., Al-Hakim A., Weiler J.M., Rethwisch D.G., Fareed J., Linhardt R.J. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J. Pharm. Sci. 81:1992;823-827.
6. Einarsson R., Andersson L.O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochim. Biophys. Acta. 490:1977;104-111.
7. Etzion Z., Meyerstein N., Yagil R. Tritiated water metabolism during dehydration and rehydration in the camel. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 56:1984;217-220.
8. Grant A.C., Linhardt R.J., Fitzgerald G., Park J.J., Langer R. Metachromatic activity of heparin and heparin fragments. Anal. Biochem. 17:1984;25-32.
9. Griffin C.C., Linhardt R.J., Van Gorp C.L., et al. Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin. Carbohyd. Res. 276:1995;183-197.
10. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The binding of low-molecular-weight to hemostatic enzymes. J. Biol. Chem. 255:1980;10073-10080.
11. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular-weight heparin. J. Biol. Chem. 255:1980;10081-10090.
12. Jordan R.E., Favreau L.V., Braswell E.H., Rosenberg R.D. Heparin with two binding sites for antithrombin or platelets factor 4. J. Biol. Chem. 257:1982;400-406.
13. Kim Y.S., Linhardt R.J. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin. Thromb. Res. 53:1989;55-71.
14. Linhardt R.J., Loganathan D., Al-Hakim A., et al. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. J. Med. Chem. 33:1990;1639-1645.
15. Linhardt R.J., Ampofo S.A., Fareed J., Hoppensteadt D., Mulliken J.B., Folkman J. Isolation and characterization of human heparin. Biochemistry. 31:1992;12441-12445.
16. Linhardt R.J., Gunay N.S. Production and chemical processing of low molecular weight heparins. Sem. Thrombos. Hemostas. 25:1999;5-16.
17. Loganathan D., Wang H.M., Mallis L.M., Linhardt R.J. Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources. Biochemistry. 29:1990;4362-4368.
18. Merchant Z.M., Kim Y.S., Rice K.G., Linhardt R.J. Structure of heparin-derived tetrasaccharides. Biochem. J. 229:1985;369-377.
19. Pervin A., Gallo C., Jandik K.A., Han X., Linhardt R.J. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology. 5:1995;83-95.
20. Quinsey N.S., Whisstock J.C., Le Bonniec B., Louvain V., Bottomley S.P., Pike R.N. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide. J. Biol. Chem. 277:2002;15971-15978.
21. Rosenberg R.D. Heparin action. Circulation. 49:1974;603-605.
22. Schonberger L.B. New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Infect. Dis. Clin. N. Am. 12:1998;111-121.
23. Teien A.N., Lie M., Abildgaard U. Assay of heparin in plasma using a chromogenic substrate. Thromb. Res. 8:1976;413-416.
24. Teien A.N., Lei M. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb. Res. 10:1977;399-410.
25. Thanawiroon C., Linhardt R.J. Separation of complex mixture of heparin derived oligosaccharides using reversed-phase high performance liquid chromatography. J. Chromatogr. A. 1014:2003;215-223.
26. Toida T., Yoshida H., Toyoda H., et al. Structural differences and the presence of unsubstituted amino groups in heparin sulphates from different tissues and species. Biochem. J. 322:1997;499-506.
27. Warda, M., 1998. Some aspects of osmoregulation in one humped camel. Ph.D. Thesis, Biochemistry and Chemistry of Nutrition Dept., Faculty of Veterinary Medicine, Cairo University. Giza 12211, Egypt.
28. Warda M., Mao W., Toida T., Linhardt R.J. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans. Comp. Biochem. Physiol. B. 134:2003;189-197.